Medifast, Inc. (MED)
After hours:
| Previous close | 111.45 |
| Open | 111.04 |
| Bid | 0.00 x 1000 |
| Ask | 0.00 x 1200 |
| Day's range | 108.26 - 116.31 |
| 52-week range | 96.00 - 200.82 |
| Volume | |
| Avg. volume | 139,536 |
| Market cap | 1.257B |
| Beta (5Y monthly) | 1.24 |
| PE ratio (TTM) | 8.71 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 6.56 (5.74%) |
| Ex-dividend date | 19 Dec 2022 |
| 1y target est | N/A |
- PR Newswire
Medifast Announces Quarterly Dividend
Medifast (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, announced today that its Board of Directors has declared a $1.64 quarterly cash dividend to its stockholders. The quarterly cash dividend of $1.64 per share is payable on February 7, 2023, to stockholders of record as of the close of business on December 20, 2022.
- PR Newswire
Medifast Survey Indicates Consumer Focus on Health and Wellbeing Remains Strong
Medifast (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, today released findings from a survey designed to further understand the shift in the spending habits of U.S. adults and how they are prioritizing their health and wellbeing heading into 2023.
- PR Newswire
Medifast Named to the 2022 FORTUNE 100 Fastest-Growing Companies List
Medifast (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, today announced that it was named to FORTUNE Magazine's 2022 list of the 100 Fastest-Growing Companies. This recognition marks the company's fourth straight year of inclusion on the prestigious list, with Medifast being one of only 24 companies returning to the list from 2021 and one of only 11 companies that made the list for three or more consecutive years.
